Repurposing Etoposide for Caries Prevention: In Vivo Efficacy and In Vitro Inhibition of Streptococcus mutans Virulence

A vicrk signal transduction system in streptococcus mutans affects gtfbcd, gbpb, and ftf expression, biofilm formation, and genetic competence development

10.1128/jb.187.12.4064-4076.2005 · doi-reference

A quorum-sensing signaling system essential for genetic competence in streptococcus mutans is involved in biofilm formation

10.1128/jb.184.10.2699-2708.2002 · doi-reference

Role of streptococcus mutans surface proteins for biofilm formation

10.1016/j.jdsr.2017.08.002 · doi-reference

The virulence of streptococcus mutans and the ability to form biofilms

10.1007/s10096-013-1993-7 · doi-reference

Applications of hydrogels in drug delivery for oral and maxillofacial diseases

10.3390/gels9020146 · doi-reference

Polymeric biomaterials for topical drug delivery in the oral cavity: advances on devices and manufacturing technologies

10.3390/pharmaceutics15010012 · doi-reference

Etoposide, an anticancer drug involved in therapy-related secondary leukemia: enzymes at play

10.1016/j.tranon.2021.101169 · doi-reference

d -histidine inhibits streptococcus mutans growth as a potential anti-caries agent

10.1080/20002297.2025.2533174 · doi-reference

The advancement of nanosystems for drug delivery in the prevention and treatment of dental caries

10.3389/fcimb.2025.1546816 · doi-reference

Plant-derived exosome-like nanovesicles: current progress and prospects

10.2147/ijn.s420748 · doi-reference

The biofilm matrix: multitasking in a shared space

10.1038/s41579-022-00791-0 · doi-reference

Intra-oral hydrogen-ion concentrations associated with dental caries activity

10.1177/00220345440230040401 · doi-reference

Sodium houttuyfonate inhibits the cariogenic virulence of streptococcus mutans through the downregulation of vicrk two components pathway

10.1080/20002297.2025.2465345 · doi-reference

Novel lactotransferrin-derived antimicrobial peptide lf-1 inhibits the cariogenic virulence factors of streptococcus mutans

10.3390/antibiotics12030563 · doi-reference

Dihydromyricetin attenuates biofilm formation and virulence in streptococcus mutans, the key pathogen underlying dental caries

10.1080/20002297.2026.2645305 · doi-reference

Zoliflodacin inhibits streptococcus mutans biofilms

10.3389/fcimb.2025.1750551 · doi-reference

Improved anti-biofilm effect against the oral cariogenic streptococcus mutans by combined triclosan/cbd treatment

10.3390/biomedicines11020521 · doi-reference

Inhibitory effects of berberine against streptococcus mutans: an in vitro insight on its anticaries potential

10.1128/spectrum.00700-25 · doi-reference

Dental caries in the molar teeth of rats: II. a method for diagnosing and scoring several types of lesions simultaneously

10.1177/00220345580370060901 · doi-reference

Rodent model in caries research

10.1007/s10266-012-0091-0 · doi-reference

Dental caries in the molar teeth of rats: i. distribution of lesions induced by high-carbohydrate low-fat diets

10.1177/00220345580370060801 · doi-reference

A comparison of the dental caries experience in male and female rats receiving the same amount of cariogenic diet

10.1177/00220345590380060401 · doi-reference

A comparison of the adaptive response of staphylococcus aureus vs. streptococcus mutans and the development of chlorhexidine resistance

10.3389/fmicb.2022.861890 · doi-reference

Repurposing the antibacterial activity of etoposide-a chemotherapeutic drug in combination with eggshell-derived hydroxyapatite

10.1021/acsbiomaterials.1c01481 · doi-reference

Structural basis of dna gyrase inhibition by antibacterial qpt-1, anticancer drug etoposide and moxifloxacin

10.1038/ncomms10048 · doi-reference

Etoposide: four decades of development of a topoisomerase ii inhibitor

10.1016/s0959-8049(98)00228-7 · doi-reference

Illuminating the oral microbiome and its host interactions: animal models of disease

10.1093/femsre/fuad018 · doi-reference

Topical ferumoxytol nanoparticles disrupt biofilms and prevent tooth decay in vivo via intrinsic catalytic activity

10.1038/s41467-018-05342-x · doi-reference

Drug repurposing to overcome microbial resistance

10.1016/j.drudis.2022.05.006 · doi-reference

Carmofur exhibits antimicrobial activity against streptococcus pneumoniae

10.3390/antibiotics14030231 · doi-reference

Reverse repurposing: potential utility of cancer drugs in nonmalignant illnesses

10.1016/j.medj.2024.04.008 · doi-reference

Drug repurposing: progress, challenges and recommendations

10.1038/nrd.2018.168 · doi-reference

Fluoride resistance in streptococcus mutans : a mini review

10.1080/20002297.2017.1344509 · doi-reference

In vitro antimicrobial effect of tetrahydrocannabinol on streptococcus mutans and its anticariogenic potential

10.1016/j.identj.2025.109386 · doi-reference

Impact of brief exposure to lysozyme and lactoferrin on pathogenic attributes of oral candida

10.1016/j.identj.2024.04.003 · doi-reference

Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria

10.1093/femsre/fux010 · doi-reference

The biology of streptococcus mutans

10.1128/microbiolspec.gpp3-0051-2018 · doi-reference

Biology of streptococcus mutans-derived glucosyltransferases: role in extracellular matrix formation of cariogenic biofilms

10.1159/000324598 · doi-reference

The exopolysaccharide matrix: a virulence determinant of cariogenic biofilm

10.1177/0022034513504218 · doi-reference

Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures

10.1111/j.1600-0757.2010.00360.x · doi-reference